NPF Submits Coalition Letter Urging Congress to Enact the Safe Step Act By End of 116th Congress


Step therapy has resulted in severe and irreversible health outcomes for many patients. There is an urgent need to pass reform so patients and their providers can access an appeals process to make a medically reasoned case to get to the right treatment at the right time, and so that fewer patients are hurt by delays in receiving appropriate care and treatments. We are pleased that a bipartisan group of 170 lawmakers have sponsored or cosponsored the Safe Step Act (HR 2279 and S 2546) this Congress. We urge Congress to enact this bipartisan legislation in the 116th Congress. Absent action this year, we urge you to commit to promptly advancing the Safe Step Act early in the 117th Congress.

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2024 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.